# Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease

> **NCT07473323** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Mediar Therapeutics** · enrollment: 88 (estimated)

## Conditions studied

- Healthy Adult Participants
- Diabetic Kidney Disease

## Interventions

- **BIOLOGICAL:** MTX-439
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07473323
- **Lead sponsor:** Mediar Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2027-05
- **Final completion:** 2028-01
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07473323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07473323, "Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07473323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*